Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
MCDERMID v. INOVIO PHARMACEUTICALS, INC. et al
Case Number:
2:20-cv-01402
Court:
Nature of Suit:
Other Statutes: Securities/Commodities
Multi Party Litigation:
Class Action
Judge:
Firms
- Berger Montague
- Block & Leviton
- Cooley LLP
- Donovan Litigation
- Duane Morris
- Fisher Zucker
- Glancy Prongay
- Goldman Scarlato
- Robbins Geller
- Sacks Weston
- Shuman Glenn
- Wolf Haldenstein
Companies
Sectors & Industries:
-
March 13, 2020
Inovio Investors Sue After COVID-19 Vaccine Claims Busted
Inovio Pharmaceuticals Inc.'s stock value skyrocketed after its CEO claimed it was ready to test a COVID-19 vaccine, but a single skeptical tweet caused shares to plummet over two days, a proposed class of shareholders alleged Friday in Philadelphia federal court.
- ← Previous
- 1
- 2
- Next →